Market Overview:
The global topical drugs glass packaging market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for topical drugs, especially in developing countries. In addition, the growing awareness about the benefits of using topical drugs is also contributing to the growth of this market. The global topical drugs glass packaging market can be segmented on the basis of type into liquid medicine, solid medicine and semi-solid medicine. The liquid medicine segment is expected to account for a major share of the global market due to its high usage in hospitals and clinics across different regions. On the other hand, solid medicines are witnessing a higher adoption rate due their easy availability and low cost as compared to other types of medicines.
Product Definition:
Topical Drugs Glass Packaging is a type of packaging that is specifically designed for topical drugs. These packages are made from glass and are often used to store creams, lotions, ointments, and other similar products. The main benefit of using this type of packaging is that it helps to protect the product from light exposure and oxidation. This can help to preserve the quality of the product over time.
Liquid Medicine:
Liquid medicine is a drug in its liquid form, which is usually dispensed by syringe or dropper. It may also be administered by directly pouring it into the mouth. The most common forms of liquid medicines are oral liquids and injections. Liquid medicines are more convenient to use as compared to their solid counterparts as they can be easily administered without any hassle of preparation and need not be stored at a particular temperature.
Solid Medicine:
Solid medicines are those that are manufactured in the form of a single dosage unit and most often administered orally. Solid dosage forms include tablets, capsules, syrups, granules and powders. These products can be used with Topical Drugs (OTDs) or as stand-alone drugs.
Application Insights:
Based on the application, the topical drugs glass packaging market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to increasing incidences of chronic diseases such as diabetes and cancer which require regular medication. Moreover, an increase in healthcare spending by governments as well as private organizations to provide better treatment facilities for patients is expected to fuel product demand over the forecast period.
The other application segment includes pharma-grade liquid medicine bottles used for compounding or customizing pharmaceutical formulations. These are majorly used for preparing customized solutions that are required to treat unique patient situations requiring additional attention from healthcare providers such as pregnancy or pediatric indications or allergies to medicines containing peanuts or soy products respectively. Such factors are anticipated to drive product demand over the forecast period thereby propelling growth of this market at a CAGR of XX%.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high adoption rate for new topical drugs. The U.S., in particular, is one of the most lucrative markets for topicals due to factors such as advanced healthcare infrastructure, high disposable income, and rising awareness among people about various treatment options available for chronic diseases.
Asia Pacific is expected to be one of the fastest-growing regions over the forecast period owing to increasing demand from developing countries such as China and India. Moreover, an increase in per capita income levels coupled with growing medical tourism will boost regional growth further on account of more people opting for these products over traditional ones resulting into greater penetration rates over time.
Growth Factors:
- Increasing demand for topical drugs from the developing countries
- Rising awareness about the benefits of using topical drugs over oral medications
- Technological advancements in glass packaging industry that are making it more user-friendly and sustainable
- Growing preference for convenience and portability among consumers, which is driving the demand for smaller and lightweight packaging formats
- Proliferation of online retail channels that are offering a wider variety of glass packaging products at competitive prices
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Drugs Glass Packaging Market Research Report
By Type
Liquid Medicine, Solid Medicine, Semi-Solid Medicine
By Application
Hospital, Clinic, Other
By Companies
Origin Pharma Packaging, Halo Pharma, Johnson & Johnson, Novartis AG, GlaxoSmithKline, Bausch Health companies, Merk & Co, Bayer AG, Aphena Pharma Solutions, Glenmark Pharmaceuticals, Allergan, West Pharmaceutical Services, Encore Dermatology, Aclaris Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Topical Drugs Glass Packaging Market Report Segments:
The global Topical Drugs Glass Packaging market is segmented on the basis of:
Types
Liquid Medicine, Solid Medicine, Semi-Solid Medicine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Origin Pharma Packaging
- Halo Pharma
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline
- Bausch Health companies
- Merk & Co
- Bayer AG
- Aphena Pharma Solutions
- Glenmark Pharmaceuticals
- Allergan
- West Pharmaceutical Services
- Encore Dermatology
- Aclaris Therapeutics
Highlights of The Topical Drugs Glass Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Medicine
- Solid Medicine
- Semi-Solid Medicine
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Drugs Glass Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical drugs are medications that are applied to the skin. Topical drugs come in a variety of packaging, including glass and plastic bottles, tubes, and aerosols.
Some of the key players operating in the topical drugs glass packaging market are Origin Pharma Packaging, Halo Pharma, Johnson & Johnson, Novartis AG, GlaxoSmithKline, Bausch Health companies, Merk & Co, Bayer AG, Aphena Pharma Solutions, Glenmark Pharmaceuticals, Allergan, West Pharmaceutical Services, Encore Dermatology, Aclaris Therapeutics.
The topical drugs glass packaging market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Topical Drugs Glass Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Topical Drugs Glass Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Topical Drugs Glass Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Topical Drugs Glass Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Topical Drugs Glass Packaging Market Size & Forecast, 2018-2028
4.5.1 Topical Drugs Glass Packaging Market Size and Y-o-Y Growth
4.5.2 Topical Drugs Glass Packaging Market Absolute $ Opportunity
Chapter 5 Global Topical Drugs Glass Packaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Topical Drugs Glass Packaging Market Size Forecast by Type
5.2.1 Liquid Medicine
5.2.2 Solid Medicine
5.2.3 Semi-Solid Medicine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Topical Drugs Glass Packaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Topical Drugs Glass Packaging Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Topical Drugs Glass Packaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Topical Drugs Glass Packaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Topical Drugs Glass Packaging Analysis and Forecast
9.1 Introduction
9.2 North America Topical Drugs Glass Packaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Topical Drugs Glass Packaging Market Size Forecast by Type
9.6.1 Liquid Medicine
9.6.2 Solid Medicine
9.6.3 Semi-Solid Medicine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Topical Drugs Glass Packaging Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Topical Drugs Glass Packaging Analysis and Forecast
10.1 Introduction
10.2 Europe Topical Drugs Glass Packaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Topical Drugs Glass Packaging Market Size Forecast by Type
10.6.1 Liquid Medicine
10.6.2 Solid Medicine
10.6.3 Semi-Solid Medicine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Topical Drugs Glass Packaging Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Topical Drugs Glass Packaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Topical Drugs Glass Packaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Topical Drugs Glass Packaging Market Size Forecast by Type
11.6.1 Liquid Medicine
11.6.2 Solid Medicine
11.6.3 Semi-Solid Medicine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Topical Drugs Glass Packaging Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Topical Drugs Glass Packaging Analysis and Forecast
12.1 Introduction
12.2 Latin America Topical Drugs Glass Packaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Topical Drugs Glass Packaging Market Size Forecast by Type
12.6.1 Liquid Medicine
12.6.2 Solid Medicine
12.6.3 Semi-Solid Medicine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Topical Drugs Glass Packaging Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Topical Drugs Glass Packaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Topical Drugs Glass Packaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Topical Drugs Glass Packaging Market Size Forecast by Type
13.6.1 Liquid Medicine
13.6.2 Solid Medicine
13.6.3 Semi-Solid Medicine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Topical Drugs Glass Packaging Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Topical Drugs Glass Packaging Market: Competitive Dashboard
14.2 Global Topical Drugs Glass Packaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Origin Pharma Packaging
14.3.2 Halo Pharma
14.3.3 Johnson & Johnson
14.3.4 Novartis AG
14.3.5 GlaxoSmithKline
14.3.6 Bausch Health companies
14.3.7 Merk & Co
14.3.8 Bayer AG
14.3.9 Aphena Pharma Solutions
14.3.10 Glenmark Pharmaceuticals
14.3.11 Allergan
14.3.12 West Pharmaceutical Services
14.3.13 Encore Dermatology
14.3.14 Aclaris Therapeutics
